🚀 VC round data is live in beta, check it out!
National Research Valuation Multiples
Discover revenue and EBITDA valuation multiples for National Research and similar public comparables like Medical Data Vision, TaiDoc Technology, SOPHiA Genetics, Veradigm and more.
National Research Overview
About National Research
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Founded
1981
HQ
Employees
368
Website
Financials (FY)
EV
$485M
National Research Financials
National Research reported last fiscal year revenue of $137M and EBITDA of $30M.
In the same fiscal year, National Research generated $85M in gross profit, $30M in EBITDA, and $12M in net income.
Revenue (LTM)
National Research P&L
In the most recent fiscal year, National Research reported revenue of $137M and EBITDA of $30M.
National Research expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $137M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $85M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 62% | XXX | XXX | XXX |
| EBITDA | — | XXX | $30M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 22% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 16% | XXX | XXX | XXX |
| Net Profit | — | XXX | $12M | XXX | XXX | XXX |
| Net Margin | — | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $75M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
National Research Stock Performance
National Research has current market cap of $410M, and enterprise value of $485M.
Market Cap Evolution
National Research's stock price is $18.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $485M | $410M | 0.0% | XXX | XXX | XXX | $0.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNational Research Valuation Multiples
National Research trades at 3.5x EV/Revenue multiple, and 16.0x EV/EBITDA.
EV / Revenue (LTM)
National Research Financial Valuation Multiples
As of April 19, 2026, National Research has market cap of $410M and EV of $485M.
Equity research analysts estimate National Research's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
National Research has a P/E ratio of 35.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $410M | XXX | $410M | XXX | XXX | XXX |
| EV (current) | $485M | XXX | $485M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 16.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 21.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.7x | XXX | XXX | XXX |
| P/E | — | XXX | 35.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 30.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified National Research Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
National Research Margins & Growth Rates
National Research's revenue in the last fiscal year declined by (4%).
National Research's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
National Research Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (27%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 45% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
National Research Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| National Research | XXX | XXX | XXX | XXX | XXX | XXX |
| Medical Data Vision | XXX | XXX | XXX | XXX | XXX | XXX |
| TaiDoc Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| SOPHiA Genetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Veradigm | XXX | XXX | XXX | XXX | XXX | XXX |
| Evolent Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
National Research M&A Activity
National Research acquired XXX companies to date.
Last acquisition by National Research was on XXXXXXXX, XXXXX. National Research acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by National Research
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNational Research Investment Activity
National Research invested in XXX companies to date.
National Research made its latest investment on XXXXXXXX, XXXXX. National Research invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by National Research
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout National Research
| When was National Research founded? | National Research was founded in 1981. |
| Where is National Research headquartered? | National Research is headquartered in United States. |
| How many employees does National Research have? | As of today, National Research has over 368 employees. |
| Who is the CEO of National Research? | National Research's CEO is Trent Green. |
| Is National Research publicly listed? | Yes, National Research is a public company listed on Nasdaq. |
| What is the stock symbol of National Research? | National Research trades under NRC ticker. |
| When did National Research go public? | National Research went public in 1997. |
| Who are competitors of National Research? | National Research main competitors are Medical Data Vision, TaiDoc Technology, SOPHiA Genetics, Veradigm. |
| What is the current market cap of National Research? | National Research's current market cap is $410M. |
| What is the current revenue of National Research? | National Research's last fiscal year revenue is $137M. |
| What is the current EV/Revenue multiple of National Research? | Current revenue multiple of National Research is 3.5x. |
| Is National Research profitable? | No, National Research is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.